VWF and COVID-19: A massive release of plasma VWF is associated with an increase of the high-molecular-weight multimers, and a slight decrease in ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type I repeats-13) levels or function, that is likely drive to the generation of microthrombosis in COVID-19 (10).